NCI-H596细胞
文献支持

NCI-H596细胞

收藏
  • ¥1320
  • BHcell(博辉生物)
  • BH-C180
  • 2025年11月27日
    avatar
  • 企业认证

    点击 QQ 联系

  • 万千商家帮你免费找货

    0 人在求购买到急需产品
    • 详细信息
    • 文献和实验
    • 技术资料
    • 规格

      T25

    NCI-H596/NCI-H596细胞系/NCI-H596细胞株/NCI-H596人肺腺鳞癌细胞

    Cell line name NCI-H596

    Synonyms H596; H-596; NCI-HUT-596; NCIH596

    Accession CVCL_1571

    Resource Identification Initiative To cite this cell line use: NCI-H596 (RRID:CVCL_1571)

    Comments Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).

    Part of: COSMIC cell lines project.

    Part of: EGFR genetic alteration cell panel (ATCC TCP-1027).

    Part of: MD Anderson Cell Lines Project.

    Part of: PI3K genetic alteration cell panel (ATCC TCP-1028).

    Population: Caucasian.

    Doubling time: 41.1 hours (PubMed=29681454).

    Microsatellite instability: Stable (MSS) (Sanger).

    Omics: Deep exome analysis.

    Omics: Deep proteome analysis.

    Omics: Deep quantitative proteome analysis.

    Omics: DNA methylation analysis.

    Omics: Protein expression by reverse-phase protein arrays.

    Omics: SNP array analysis.

    Omics: Transcriptome analysis by microarray.

    Omics: Transcriptome analysis by RNAseq.

    Derived from site: In situ; Lung; UBERON=UBERON_0002048.

    PubMed=8806092; DOI=10.1002/jcb.240630505

    Phelps R.M., Johnson B.E., Ihde D.C., Gazdar A.F., Carbone D.P., McClintock P.R., Linnoila R.I., Matthews M.J., Bunn P.A. Jr., Carney D.N., Minna J.D., Mulshine J.L.

    NCI-Navy Medical Oncology Branch cell line data base.

    J. Cell. Biochem. Suppl. 24:32-91(1996)

     

    PubMed=8806101; DOI=10.1002/jcb.240630514

    Lokshin A.E., Levitt M.L.

    Effect of suramin on squamous differentiation and apoptosis in three human non-small-cell lung cancer cell lines.

    J. Cell. Biochem. Suppl. 24:186-197(1996)

     

    PubMed=10536175; DOI=10.3892/ijo.15.5.927

    Fujita T., Kiyama M., Tomizawa Y., Kohno T., Yokota J.

    Comprehensive analysis of p53 gene mutation characteristics in lung carcinoma with special reference to histological subtypes.

    Int. J. Oncol. 15:927-934(1999)

     

    PubMed=11005564; DOI=10.1038/sj.neo.7900094; PMCID=PMC1550293

    Kohno T., Sato T., Takakura S., Takei K., Inoue K., Nishioka M., Yokota J.

    Mutation and expression of the DCC gene in human lung cancer.

    Neoplasia 2:300-305(2000)

     

    PubMed=11030152; DOI=10.1038/sj.onc.1203815

    Modi S., Kubo A., Oie H.K., Coxon A.B., Rehmatulla A., Kaye F.J.

    Protein expression of the RB-related gene family and SV40 large T antigen in mesothelioma and lung cancer.

    Oncogene 19:4632-4639(2000)

     

    PubMed=19472407; DOI=10.1002/humu.21028; PMCID=PMC2900846

    Blanco R., Iwakawa R., Tang M.-Y., Kohno T., Angulo B., Pio R., Montuenga L.M., Minna J.D., Yokota J., Sanchez-Cespedes M.

    A gene-alteration profile of human lung cancer cell lines.

    Hum. Mutat. 30:1199-1206(2009)

     

    PubMed=20164919; DOI=10.1038/nature08768; PMCID=PMC3145113

    Bignell G.R., Greenman C.D., Davies H.R., Butler A.P., Edkins S., Andrews J.M., Buck G., Chen L., Beare D., Latimer C., Widaa S., Hinton J., Fahey C., Fu B.-Y., Swamy S., Dalgliesh G.L., Teh B.T., Deloukas P., Yang F.-T., Campbell P.J., Futreal P.A., Stratton M.R.

    Signatures of mutation and selection in the cancer genome.

    Nature 463:893-898(2010)

     

    PubMed=20215515; DOI=10.1158/0008-5472.CAN-09-3458; PMCID=PMC2881662

    Rothenberg S.M., Mohapatra G., Rivera M.N., Winokur D., Greninger P., Nitta M., Sadow P.M., Sooriyakumar G., Brannigan B.W., Ulman M.J., Perera R.M., Wang R., Tam A., Ma X.-J., Erlander M., Sgroi D.C., Rocco J.W., Lingen M.W., Cohen E.E.W., Louis D.N., Settleman J., Haber D.A.

    A genome-wide screen for microdeletions reveals disruption of polarity complex genes in diverse human cancers.

    Cancer Res. 70:2158-2164(2010)

     

    PubMed=20557307; DOI=10.1111/j.1349-7006.2010.01622.x; PMCID=PMC11158680

    Iwakawa R., Kohno T., Enari M., Kiyono T., Yokota J.

    Prevalence of human papillomavirus 16/18/33 infection and p53 mutation in lung adenocarcinoma.

    Cancer Sci. 101:1891-1896(2010)

     

    PubMed=22460905; DOI=10.1038/nature11003; PMCID=PMC3320027

    Barretina J.G., Caponigro G., Stransky N., Venkatesan K., Margolin A.A., Kim S., Wilson C.J., Lehar J., Kryukov G.V., Sonkin D., Reddy A., Liu M., Murray L., Berger M.F., Monahan J.E., Morais P., Meltzer J., Korejwa A., Jane-Valbuena J., Mapa F.A., Thibault J., Bric-Furlong E., Raman P., Shipway A., Engels I.H., Cheng J., Yu G.-Y.K., Yu J.-J., Aspesi P. Jr., de Silva M., Jagtap K., Jones M.D., Wang L., Hatton C., Palescandolo E., Gupta S., Mahan S., Sougnez C., Onofrio R.C., Liefeld T., MacConaill L.E., Winckler W., Reich M., Li N.-X., Mesirov J.P., Gabriel S.B., Getz G., Ardlie K., Chan V., Myer V.E., Weber B.L., Porter J., Warmuth M., Finan P., Harris J.L., Meyerson M.L., Golub T.R., Morrissey M.P., Sellers W.R., Schlegel R., Garraway L.A.

    The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity.

    Nature 483:603-607(2012)

    风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。

    图标文献和实验
    该产品被引用文献

    *发表【中文论文】请标注:由博辉生物科技(广州)有限公司提供; *发表【英文论文】请标注:From Bohui Biological Technology (Guangzhou) Co., Ltd.

    图标技术资料

    资料下载:

    NCI-H596(BH-C180).docx 附 (下载 0 次)

    同类产品报价

    产品名称
    产品价格
    公司名称
    报价日期
    ¥900
    上海泽叶生物科技有限公司
    2025年11月25日询价
    ¥1680
    吉奥蓝图(广东)生命科学技术中心
    2025年09月23日询价
    ¥900
    上海淳麦生物科技有限公司
    2025年07月16日询价
    询价
    蒂科(上海)生物科技有限公司
    2025年07月11日询价
    ¥1480
    上海酶研生物科技有限公司
    2025年07月11日询价
    文献支持
    NCI-H596细胞
    ¥1320